UBS Maintains Buy on XP, Raises Price Target to $28

Benzinga Newsdesk www.benzinga.com Positive 81.6%

Neg 0% Neu 0% Pos 81.6%

UBS analyst Thiago Batista maintains XP (NASDAQ:XP) with a Buy and raises the price target from $25 to $28.

Comments

No comments yet. Be the first!